Novel Factor XIa Inhibitors Show Promise for Bleeding Risk

(MedPage Today) -- BARCELONA--Researchers here showed overall enthusiasm for factor XIa inhibitors, which have been shown to keep bleeding at bay when added to standard dual antiplatelet therapy, though there were only hints of efficacy in...